|
US3734795A
(en)
|
1971-04-23 |
1973-05-22 |
Lindsay Wire Weaving Co |
Patch and seam for plastic belts
|
|
US6635743B1
(en)
|
1996-03-22 |
2003-10-21 |
Human Genome Sciences, Inc. |
Apoptosis inducing molecule II and methods of use
|
|
US7964190B2
(en)
|
1996-03-22 |
2011-06-21 |
Human Genome Sciences, Inc. |
Methods and compositions for decreasing T-cell activity
|
|
EP0985033A4
(en)
|
1997-04-04 |
2005-07-13 |
Biosite Inc |
POLYVALENT AND POLYCLONAL LIBRARIES
|
|
US6140467A
(en)
|
1997-07-07 |
2000-10-31 |
La Jolla Institute For Allergy And Immunology |
Ligand for herpes simplex virus entry mediator and methods of use
|
|
US6998108B1
(en)
|
1997-07-07 |
2006-02-14 |
La Jolla Institute For Allergy And Immunology |
Antibodies to p30 polypeptides and methods making and using same
|
|
US7118742B2
(en)
|
1997-07-07 |
2006-10-10 |
La Jolla Institute For Allergy And Immunology |
Ligand for herpes simplex virus entry mediator and methods of use
|
|
ATE365214T1
(de)
|
2000-04-12 |
2007-07-15 |
Jolla Inst Allergy Immunolog |
Ligand des zelleintritt-vermittelnden proteins von herpes simplex und methoden zu dessen verwendungen
|
|
EP1336619A3
(en)
|
2002-02-19 |
2003-12-10 |
Millenium Pharmaceuticals, Inc. |
Combination of a HVEM-LIGHT inhibitor and an immunosuppressive agent in the treatment or prevention of immune disorders
|
|
WO2003089575A2
(en)
*
|
2002-04-15 |
2003-10-30 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to tl5
|
|
EP2484696B1
(en)
*
|
2006-08-28 |
2017-08-16 |
Kyowa Hakko Kirin Co., Ltd. |
Antagonistic hLIGHT-specific human monoclonal antibodies
|
|
ZA200901165B
(en)
*
|
2006-08-28 |
2010-06-30 |
Kyowa Hakko Kirin Co Ltd |
Antagonistic human light-specific human monoclonal antibodies
|
|
US8440185B2
(en)
|
2006-12-26 |
2013-05-14 |
The Johns Hopkins University |
Compositions and methods for the treatment of immunologic disorders
|
|
AU2008255352B2
(en)
|
2007-05-31 |
2014-05-22 |
Genmab A/S |
Stable IgG4 antibodies
|
|
EP3750554A3
(en)
|
2007-09-18 |
2021-07-28 |
La Jolla Institute for Allergy and Immunology |
Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment
|
|
JP2012507299A
(ja)
*
|
2008-10-31 |
2012-03-29 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
Ｌｉｇｈｔ標的分子およびその使用
|
|
WO2010111180A1
(en)
|
2009-03-24 |
2010-09-30 |
Teva Biopharmaceuticals Usa, Inc. |
Humanized antibodies against light and uses thereof
|
|
US9592289B2
(en)
|
2012-03-26 |
2017-03-14 |
Sanofi |
Stable IgG4 based binding agent formulations
|
|
JP6265970B2
(ja)
*
|
2012-03-26 |
2018-01-24 |
サノフイ |
安定なＩｇＧ４に基づく結合剤の製剤
|
|
US20130315913A1
(en)
*
|
2012-03-26 |
2013-11-28 |
Sanofi |
Anti-light antibody therapy for inflammatory bowel disease
|
|
AU2014318014C1
(en)
|
2013-09-06 |
2018-11-15 |
Research Development Foundation |
Alpha-tea salt forms: compositions and uses for treating disease
|
|
WO2015061752A1
(en)
|
2013-10-25 |
2015-04-30 |
Pharmacyclics, Inc. |
Treatment using bruton's tyrosine kinase inhibitors and immunotherapy
|
|
JP2017504327A
(ja)
|
2014-01-14 |
2017-02-09 |
カイマブ・リミテッド |
抗ｌｉｇｈｔ抗体
|
|
WO2015155738A2
(en)
|
2014-04-09 |
2015-10-15 |
Christopher Rudd |
Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
|
|
US20180016345A1
(en)
|
2015-02-05 |
2018-01-18 |
La Jolla Institute For Allergy And Immunology |
Light inhibitors for scleroderma and skin fibrotic disease treatment
|
|
HK1257443A1
(zh)
|
2015-08-21 |
2019-10-18 |
The Children's Hospital Of Philadelphia |
治疗具有dcr3或dcr3网络基因中的遗传变异的患者的自身免疫病症的方法
|
|
US11312781B2
(en)
*
|
2018-01-24 |
2022-04-26 |
Capella Bioscience Ltd. |
Antigen binding molecules that bind LIGHT
|